Cargando…
Tumoral PD-L1 expression defines a subgroup of poor-prognosis vulvar carcinomas with non-viral etiology
Vulvar cancer is rare but incidence rates are increasing due to an aging population and higher frequencies of young women being affected. In locally advanced, metastatic or recurrent disease prognosis is poor and new treatment modalities are needed. Immune checkpoint blockade of the PD-1/PD-L1 pathw...
Autores principales: | Hecking, Thomas, Thiesler, Thore, Schiller, Cynthia, Lunkenheimer, Jean-Marc, Ayub, Tiyasha H., Rohr, Andrea, Condic, Mateja, Keyver-Paik, Mignon-Denise, Fimmers, Rolf, Kirfel, Jutta, Kuhn, Walther, Kristiansen, Glen, Kübler, Kirsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696230/ https://www.ncbi.nlm.nih.gov/pubmed/29190964 http://dx.doi.org/10.18632/oncotarget.21641 |
Ejemplares similares
-
Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer
por: Ayub, Tiyasha H., et al.
Publicado: (2015) -
Individual management of cervical cancer in pregnancy
por: Hecking, Thomas, et al.
Publicado: (2016) -
TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target
por: Condic, Mateja, et al.
Publicado: (2023) -
N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma
por: Condic, Mateja, et al.
Publicado: (2022) -
The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer
por: Egger, Eva K., et al.
Publicado: (2023)